No, I’m not making this up. WebMD reports that the US Food and Drug Administration has issued approval to Allergan to market and distribute a new drug called Latisse that promotes longer, darker, thicker eyelashes.
Turns out that eyelash growth is a rather surprising side-effect of the glaucoma drug Lumigen, also made by Allergan.
Allergan states that “Latisse users can expect to experience longer, fuller, and darker eyelashes in as little as eight weeks, with full results in 16 weeks.” If Latisse is stopped, eyelashes will gradually return to their previous appearance as new eyelashes grow in.
Um, err, my response is: WHAT?
Are we living in an age where people are really going to use prescription drugs to lengthen their eyelashes, even without us fully understanding the side-effects or potential interactions between Latisse and other drugs people might well take?
Common side effects? They’ll be listed as “eye redness, itchy eyes, and skin hyperpigmentation.”
Reuters news service is also reporting on this story (albeit only in the UK) and they observe: “Allergan said it estimates global peak sales of Latisse solution could top $500 million a year…”
Theoretically it would only be used for people that have lost their eyelashes due to chemotherapy, etc., but you know as well as I do that it’ll be just a few months before Beverly Hills plastic surgeons are prescribing this as a mascara replacement, then it’ll spread across the United States. It’s no coincidence that Allergan also makes Botox…
So, dear reader, would you use Latisse to lengthen your eyelashes?